R.O.S.A.L.I.N.D Platform

About InvenireX

InvenireX is a private, pre-revenue biotech firm founded in 2018, pioneering a novel molecular diagnostics platform. The company's technology integrates DNA nanotechnology ('Nanites' for single-molecule capture) with an AI-powered instrument and software suite (R.O.S.A.L.I.N.D) to perform real-time, isothermal nucleic acid detection without enzymes or amplification. Targeting the life sciences research and diagnostic tools market, InvenireX seeks to simplify and accelerate complex molecular analysis, though it faces significant technical and commercial risks typical of an early-stage deep-tech venture.